• 1. Department of Anesthesiology; 2. Center of Evidence-based Medicine; West China Hospital, Sichuan University, Chengdu, Sichuan 610041, P. R. China;
LIU Bin, Email: gujuangujuan@163.com
Export PDF Favorites Scan Get Citation

目的  系統評價瑞芬太尼用于全身麻醉下剖宮產時對新生兒的影響。 方法  檢索Cochrane Library、PubMed、OVID、EMbase、CNKI、萬方等中外數據庫,收集1990年-2012年關于瑞芬太尼用于全身麻醉下剖宮產的臨床隨機對照研究。按Cochrane系統評價方法評估文獻質量,用Revman 5.1軟件對提取的數據進行Meta分析。 結果  共納入10項研究,包括342例產婦。與空白對照組相比,瑞芬太尼降低新生兒1 min Apgar評分[WMD=?0.46,95%CI(?0.65,?0.27),P<0.000 01],提高出生時臍動脈pH值[WMD=0.01,95%CI(0.00,0.02),P=0.004],增加出生時窒息發生率[RR=1.76,95%CI(1.06,2.95),P=0.03];當誘導劑量為1.0~1.5 μg/kg時,對5 min Apgar評分無影響[WMD=?0.14,95%CI(?0.32,0.04),P=0.13]。 結論  瑞芬太尼用于全身麻醉剖宮產可減輕新生兒酸中毒,但是會對新生兒產生一過性的呼吸抑制。

Citation: GU Juan,CHEN Jie,CHEN Yuanjing,LIU Bin. Influence of Remifentanil on Newborns During Cesarean Section under General Anesthesia: A Meta Analysis. West China Medical Journal, 2012, 27(9): 1361-1365. doi: Copy

Copyright ? the editorial department of West China Medical Journal of West China Medical Publisher. All rights reserved